{"result": "(\"entity\"<|>INSTITUTE FOR SAFE MEDICATION PRACTICES<|>ORGANIZATION<|>The Institute for Safe Medication Practices (ISMP) is an organization that focuses on medication safety and includes parenteral nutrition among high-risk medications.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional therapy administered intravenously, consisting of macro- and micronutrients for patients with specific medical conditions.)\n##\n(\"entity\"<|>TORRES TORRES B<|>PERSON<|>Torres Torres B is an author referenced in the context of parenteral nutrition research.)\n##\n(\"entity\"<|>LÓPEZ GÓMEZ JJ<|>PERSON<|>López Gómez JJ is an author referenced in the context of parenteral nutrition research.)\n##\n(\"entity\"<|>GÓMEZ HOYOS E<|>PERSON<|>Gómez Hoyos E is an author referenced in the context of parenteral nutrition research.)\n##\n(\"entity\"<|>ORTOLÁ BUIGES A<|>PERSON<|>Ortolá Buiges A is an author referenced in the context of parenteral nutrition research.)\n##\n(\"entity\"<|>DE LUIS ROMÁN DA<|>PERSON<|>De Luis Román DA is an author referenced in the context of parenteral nutrition research.)\n##\n(\"relationship\"<|>INSTITUTE FOR SAFE MEDICATION PRACTICES<|>NUTRICIÓN PARENTERAL<|>The ISMP includes parenteral nutrition among medications with a high risk of causing errors, indicating its importance in medication safety<|>8)\n##\n(\"relationship\"<|>TORRES TORRES B<|>NUTRICIÓN PARENTERAL<|>Torres Torres B is an author who contributed to the research on parenteral nutrition<|>5)\n##\n(\"relationship\"<|>LÓPEZ GÓMEZ JJ<|>NUTRICIÓN PARENTERAL<|>López Gómez JJ is an author who contributed to the research on parenteral nutrition<|>5)\n##\n(\"relationship\"<|>GÓMEZ HOYOS E<|>NUTRICIÓN PARENTERAL<|>Gómez Hoyos E is an author who contributed to the research on parenteral nutrition<|>5)\n##\n(\"relationship\"<|>ORTOLÁ BUIGES A<|>NUTRICIÓN PARENTERAL<|>Ortolá Buiges A is an author who contributed to the research on parenteral nutrition<|>5)\n##\n(\"relationship\"<|>DE LUIS ROMÁN DA<|>NUTRICIÓN PARENTERAL<|>De Luis Román DA is an author who contributed to the research on parenteral nutrition<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ilgliceroles de cadena larga son más estables que las que\n                   a 400 mg/dl.                                                                                                                                 contienen aceite de oliva.\n               D.  El empleo de glutamina por vía i.v. podría ser beneficioso para disminuir la morbilidad\n                   asociada a la pancreatitis aguda.\n\n\n\n218                                                                                                                                                                                                                                                                                      219\n---\n                                                                                                                                                                                                                                         NUTRICIÓN                           4\n\n\n\n         COMENTARIO                                                                                                                                  COMENTARIO\n         Una fórmula de nutrición parenteral es un conjunto de macro- y micronutrientes que se                                                       La nutrición parenteral es una mezcla compleja de decenas de sustancias. El Institute for\n         administran por vía intravenosa. Se pueden administrar a través de una vía central o de                                                     Safe Medication Practices (ISMP) incluye a la nutrición parenteral entre los medicamentos\n         una vía venosa periférica (si la osmolaridad es inferior a 900 mOsm/l). Sus indicaciones                                                    con mayor predisposición a inducir o generar errores, considerándola como un medica-\n         incluyen:                                                                                                                                   mento de alto riesgo (aquellos que, cuando se utilizan incorrectamente, presentan un ries-\n         •  Síndrome de intestino corto.                                                                                                             go elevado de causar daños graves o incluso mortales a los pacientes).\n         •  Fístula intestinal, generalmente de intestino proximal.                                                                                  La administración de fármacos en la mezcla de nutrición parenteral (NP) disminuye el nú-\n         •  Alteraciones de la motilidad intestinal.                                                                                                 mero de manipulaciones de la vía central y facilita el trabajo de enfermería, pero la mayoría\n         •  Obstrucción mecánica intestinal.                                                                                                         de los fármacos presentan problemas de estabilidad con los componentes de la NP, pudien-\n         •  Afectación extensa de la mucosa intestinal que produce malabsorción.                                                                     do originar una inestabilidad de la mezcla o disminución del efecto terapéutico del fármaco.\n         El aporte de lípidos se hace mediante emulsiones lipídicas, compuestas por una mezcla                                                       La interacción entre el fármaco y la fórmula parenteral puede producirse dentro de la bolsa\n         de aceite de soja, coco, palma o pescado, a la que se añaden fosfolípidos como agente                                                       de parenteral o durante la administración en Y.\n         emulsionante y glicerol para isotonizar. Las emulsiones lipídicas iniciales estaban for-                                                    En la elaboración de las fórmulas de nutrición parenteral deben tenerse en cuenta factores\n         madas exclusivamente              por  triglicéridos de       cadena     larga   (LCT);   las   emulsiones de        se-                    como la cantidad de micronutrientes, el orden de adición de estos, su pH, etc. Deben esta-\n         gunda generación aportan triglicéridos de cadena media (MCT), que se caracterizan por                                                       blecerse algunas medidas para garantizar la estabilidad de la fórmula:\n         su rápida oxidación, por ser resistentes a la peroxidación lipídica, por no almacenarse                                                     •  No mezclar directamente glucosa y lípidos, sin la presencia de aminoácidos.\n         como triglicéridos (con menor riesgo de esteatosis hepática) y por ser inflamatoriamente                                                    •  No mezclar los oligoelementos y vitaminas juntos en la misma solución de macronutrien-\n         neutros. Las emulsiones de tercera generación incorporan ácido oleico, con una elevada                                                         tes.\n         resistencia a la peroxidación. Finalmente, las emulsiones de cuarta generación añaden                                                       •  Utilizar una jeringa de forma exclusiva para cada componente.\n         ácidos grasos ω-3.                                                                                                                          •  Nunca introducir en el mismo envase de macronutrientes los aportes de calcio, magnesio\n         El volumen de la nutrición parenteral debe adaptarse a los requerimientos del pacien-                                                          y fosfato.\n         te, teniendo en cuenta las pérdidas y el aporte de volumen. El volumen de la fórmula                                                        •  Incorporar el calcio a la bolsa siempre en último lugar, siempre antes de la emulsión\n         parenteral puede modificarse al elaborarla jugando con las diferentes concentraciones                                                          lipídica.\n         comercializadas de glucosa (5-70%), aminoácidos (10-15%) y grasas (10-30%).                                                                 •  No añadir el fosfato y el calcio de forma secuencial.\n         Referencias:                                                                                                                                •  No añadir electrolitos a la emulsión lipídica.\n         • Torres Torres B, López Gómez JJ, Gómez Hoyos E, Ortolá Buiges A, de Luis Román DA. Nutrición parenteral. En: de Luis DA, Bellido          •  Emplear solo gluconato cálcico para evitar errores de cálculo con el cloruro cálcico.\n           Guerrero D, García Luna\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}